MEDICAMEN BIOTECH
Back to Cashflow Statement
|
MEDICAMEN BIOTECH Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹29 Cr | ₹4.30 Cr | ₹5.84 Cr | ₹19 Cr | ₹-3.69 Cr |
What is the latest Cash Flow from Financing Activities ratio of MEDICAMEN BIOTECH ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2023 | ₹29 Cr |
Mar2022 | ₹4.30 Cr |
Mar2021 | ₹5.84 Cr |
Mar2020 | ₹19 Cr |
Mar2019 | ₹-3.69 Cr |
How is Cash Flow from Financing Activities of MEDICAMEN BIOTECH Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2023 | ₹29 Cr | 577.69 | |
Mar2022 | ₹4.30 Cr | -26.39 | |
Mar2021 | ₹5.84 Cr | -69.37 | |
Mar2020 | ₹19 Cr | Positive | |
Mar2019 | ₹-3.69 Cr | - |
Compare Cash Flow from Financing Activities of peers of MEDICAMEN BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
MEDICAMEN BIOTECH | ₹610.3 Cr | -7.3% | -17% | -28.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹350,195.0 Cr | -1.8% | -2.9% | 52.3% | Stock Analytics | |
CIPLA | ₹118,275.0 Cr | -1.4% | 4.5% | 57% | Stock Analytics | |
DIVIS LABORATORIES | ₹117,130.0 Cr | 7% | 10.3% | 26.7% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹102,998.0 Cr | -4.9% | 7.3% | 105.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,034.1 Cr | 0.2% | -5.3% | 32.4% | Stock Analytics |
MEDICAMEN BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
MEDICAMEN BIOTECH | -7.3% |
-17% |
-28.9% |
SENSEX | -2% |
-1.1% |
19.4% |
You may also like the below Video Courses